Cancer modeling by Transgene Electroporation in Adult Zebrafish (TEAZ)

Author:

Callahan Scott J.123,Tepan Stephanie45,Zhang Yan M.1,Lindsay Helen67,Burger Alexa6,Campbell Nathaniel R.8,Kim Isabella S.1,Hollmann Travis J.9,Studer Lorenz10,Mosimann Christian6,White Richard M.111ORCID

Affiliation:

1. Memorial Sloan Kettering Cancer Center, Cancer Biology & Genetics and Department of Medicine, New York, New York 10065, USA

2. Memorial Sloan Kettering Cancer Center, Developmental Biology, New York, New York 10065, USA

3. Memorial Sloan Kettering Cancer Center, Gerstner Graduate School of Biomedical Sciences, New York, New York 10065, USA

4. Memorial Sloan Kettering Cancer Center, 2017 Summer Clinical Oncology Research Experience (SCORE) program, New York, New York 10065, USA

5. Hunter College, New York, New York 10065, USA

6. Institute of Molecular Life Sciences, University of Zurich, Zurich, Switzerland

7. SIB Swiss Insitute of Bioinformatics, University of Zurich, Zurich, Switzerland

8. Weill Cornell/Rockefeller/Sloan-Kettering Tri-Institutional MD-PhD Program, New York, New York 10065, USA

9. Memorial Sloan Kettering Cancer Center, Pathology, New York, New York 10065, USA

10. The Center for Stem Cell Biology, Sloan Kettering Institute, New York, NY 10065, USA; Developmental Biology Program, Sloan Kettering Institute, New York, NY 10065, USA

11. Weill Cornell Medical College, New York, New York 10065, USA

Abstract

Transgenic animals are invaluable for modeling cancer genomics, but often require complex crosses of multiple germline alleles to obtain the desired combinations. Zebrafish models have advantages in that transgenes can be rapidly tested by mosaic expression, but these typically lack spatial and temporal control of tumor onset, which limits their utility for the study of tumor progression and metastasis. To overcome these limitations, we have developed a method called Transgene Electroporation in Adult Zebrafish (TEAZ). TEAZ can deliver DNA constructs with promoter elements of interest to drive fluorophores, oncogenes, or CRISPR-Cas9-based mutagenic cassettes in specific cell types. Using TEAZ, we created a highly aggressive melanoma model via Cas9-mediated inactivation of Rb1 in the context of BRAFV600E in spatially constrained melanocytes. Unlike prior models that take ∼4 months to develop, we found that TEAZ leads to tumor onset in ∼7 weeks and these develop in fully immunocompetent animals. As the resulting tumors initiated at highly defined locations, we could track their progression via fluorescence and documented deep invasion into tissues and metastatic deposits. TEAZ can be deployed to other tissues and cell types such as the heart with the use of suitable transgenic promoters. The versatility of TEAZ makes it widely accessible for rapid modeling of somatic gene alterations and cancer progression at a scale not achievable in other in vivo systems.

Funder

National Institutes of Health

Melanoma Research Alliance

The Starr Cancer Consortium

The Pershing Square Sohn Foundation

The Alan and Sandra Gerry Metastasis Research Initiative at the Memorial Sloan Kettering Cancer Center

The Harry J. Lloyd Foundation

Consano and and the Memorial Sloan Kettering Cancer Center Support Grant/Core Grant

Joanna M. Nicolay Melanoma Foundation

Robert B. Catell Fellowship

National Center of Competence in Research Materials? Revolution: Computational Design and Discovery of Novel Materials

SwissBridge Foundation

FP7 People: Marie-Curie Actions

Publisher

The Company of Biologists

Subject

General Biochemistry, Genetics and Molecular Biology,Immunology and Microbiology (miscellaneous),Medicine (miscellaneous),Neuroscience (miscellaneous)

Cited by 40 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3